# EDGAR Filing Document

**Accession Number:** 0000070318
**File Stem:** 0001193125-26-159125
**Filing Date:** 2026-4
**Character Count:** 6078
**Document Hash:** adcb38f22ce4ba1c2d4bee23174b2ca7
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-159125.hdr.sgml**: 20260416

**ACCESSION NUMBER**: 0001193125-26-159125

**CONFORMED SUBMISSION TYPE**: DEFA14A

**PUBLIC DOCUMENT COUNT**: 10

**FILED AS OF DATE**: 20260416

**DATE AS OF CHANGE**: 20260416

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** TENET HEALTHCARE CORP
- **CENTRAL INDEX KEY:** 0000070318
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 952557091
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DEFA14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-07293
- **FILM NUMBER:** 26867985

**BUSINESS ADDRESS:**
- **STREET 1:** 14201 DALLAS PARKWAY
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75254
- **BUSINESS PHONE:** 469-893-2200

**MAIL ADDRESS:**
- **STREET 1:** 14201 DALLAS PARKWAY
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75254

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** NATIONAL MEDICAL ENTERPRISES INC /NV/
- **DATE OF NAME CHANGE:** 19920703

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, DC 20549** 

**SCHEDULE 14A** 

**Proxy Statement Pursuant to Section 14(a) of** 

**the Securities Exchange Act of 1934** 

**(Amendment No.)** 

Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐

Check the appropriate box:

☐ Preliminary Proxy Statement

☐ **Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))** 

☐ Definitive Proxy Statement

☒ Definitive Additional Materials

☐ Soliciting Material under Rule 14a-12

## Tenet Healthcare Corporation
**(Name of Registrant as Specified in Its Charter)** 

Payment of Filing Fee (Check the appropriate box):

☒ No fee required.

☐ Fee paid previously with preliminary materials.

☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

------

---

| | |
|:---|:---|
| ![LOGO](g928614g92w12.jpg) <br>C/O TABULATOR, P.O. BOX 8016, CARY, NC 27512-9903<br>![LOGO](g928614g92w14.jpg)  | ![LOGO](g928614g92w13.jpg) |

---

---

| | | |
|:---|:---|:---|
|  | <br> ![LOGO](g928614g92w15.jpg)  | <br> **Proxy Materials:** Notice of Annual Meeting & Proxy<br> Statement and Annual Report on Form 10-K<br>**Important Notice Regarding the Availability of Proxy Materials for the Shareholders Meeting to be held on May 27, 2026 for Shareholders of record as of April 2, 2026.** |
| <br> **Tenet Healthcare Corporation**<br>**Annual Meeting of Shareholders** | <br> ![LOGO](g928614g92w15.jpg)  | <br> **Proxy Materials:** Notice of Annual Meeting & Proxy<br> Statement and Annual Report on Form 10-K<br>**Important Notice Regarding the Availability of Proxy Materials for the Shareholders Meeting to be held on May 27, 2026 for Shareholders of record as of April 2, 2026.** |
| Wednesday, May 27, 2026 at 9:00 AM, Central Time<br>Annual Meeting to be held live via the Internet - please visit www.proxydocs.com/THC for more details.<br>**You must register to attend, participate and/or vote at the annual meeting at**<br> ***www.proxydocs.com/THC.***<br>**For a convenient way to view proxy materials, VOTE and obtain directions to attend the meeting go to *www.proxydocs.com/THC.***<br>**To vote your proxy while visiting this site, you will need the 12 digit control number in the box below.**<br>This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. This is not a ballot. You cannot use this notice to vote your shares. We encourage you to access and review all of the important information contained in the proxy materials before voting. | <br> ![LOGO](g928614g92w15.jpg)  | **To order paper materials, use one of the following methods:**<br>![LOGO](g928614g92w05.jpg) <br>**Internet:**<br> **www.investorelections.com/THC**<br>![LOGO](g928614g92w06.jpg) <br>**Call:**<br> **1-866-648-8133** |
| Under U.S. Securities and Exchange Commission rules, proxy materials do not have to be delivered in paper. Proxy materials can be distributed by making them available on the Internet.<br>If you want to receive a paper or e-mail copy of the proxy materials, you must request one. There is no charge to you for requesting a copy. In order to receive a paper package in time for this year's meeting, you must make this request on or before May 22, 2026. | <br> ![LOGO](g928614g92w15.jpg)  | <br> ![LOGO](g928614g92w07.jpg) <br>**Email:**<br> **paper@investorelections.com**<br>\* If requesting materials by e-mail, please send a blank e-mail with the 12 digit control number (located below) in the subject line. No other requests, instructions OR inquiries should be included with your e-mail requesting materials.<br>![LOGO](g928614g92w16.jpg)  |

---

<br> Have the 12 digit control number located in the box above available when you access the website and follow the instructions.<br>

**SEE REVERSE FOR FULL AGENDA** 

Copyright <sup>©</sup> 2026 BetaNXT, Inc. or its affiliates. All Rights Reserved

------

---

| | |
|:---|:---|
| ![LOGO](g928614g92w17.jpg)  | **Tenet Healthcare Corporation Annual Meeting of Shareholders** |
| ![LOGO](g928614g92w17.jpg)  |  |

---

**THE BOARD OF DIRECTORS RECOMMENDS A VOTE:** 

**FOR** EACH OF THE DIRECTOR NOMINEES LISTED IN PROPOSAL 1 AND **FOR** PROPOSALS 2 AND 3

---

| | |
|:---|:---|
|  | **PROPOSAL** |
| 1. | Election of Directors |
|  | 1.01 Saumya Sutaria |
|  | 1.02 J. Robert Kerrey |
|  | 1.03 Vineeta Agarwala |
|  | 1.04 James L. Bierman |
|  | 1.05 Roy Blunt |
|  | 1.06 Richard W. Fisher |
|  | 1.07 Meghan M. FitzGerald |
|  | 1.08 Cecil D. Haney |
|  | 1.09 Christopher S. Lynch |
|  | 1.10 Richard J. Mark |
|  | 1.11 Tammy Romo |
|  | 1.12 Nadja Y. West |
| 2. | To approve, on an advisory basis, the Company's executive compensation. |
| 3. | To ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accountants for the year ending December 31, 2026. |

---